APOB and diabetes mellitus: In a routine clinical setting, usually dealing with individual risk estimation or risk stratification between dozens to hundreds of patients, both non-HDL-C and apoB performed equally well to discriminate between diabetic patients, and may be considered as interchangeable surrogates in diabetes.